Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Article
Venneti, Sriram, Kawakibi, Abed Rahman, Ji, Sunjong et al. (2023). Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
. CANCER DISCOVERY, 13(11), 2370-2393. 10.1158/2159-8290.CD-23-0131
Venneti, Sriram, Kawakibi, Abed Rahman, Ji, Sunjong et al. (2023). Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
. CANCER DISCOVERY, 13(11), 2370-2393. 10.1158/2159-8290.CD-23-0131